All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
2,237 recalls · page 23 of 45
-
Class IIIofficial
Imprimis NJOF, LLC recalls Tropicamide-Proparacaine-Phenylephrine-KetorolacSub-Potent Drug: Subpotent assay results during stability testing.
-
Class IIofficial
Strides Pharma, Inc. recalls Cinacalcet Tablets 90 mgFailed Dissolution Specifications.
-
Class IIofficial
Boothwyn Pharmacy LLC recalls SemaglutideSubpotent Drug
-
Class IIIofficial
Boothwyn Pharmacy LLC recalls Fluorescein 2% OphthSubpotent Drug
-
Class IIofficial
Boothwyn Pharmacy LLC recalls SemaglutideSubpotent Drug
-
Class IIofficial
Boothwyn Pharmacy LLC recalls SemaglutideSubpotent Drug
-
Class IIofficial
MEDLINE INDUSTRIES, LP - Northfield recalls Medline Alcohol Prep PadsSubpotent Drug- isopropyl alcohol levels fall below the labeled concentration.
-
Class IIofficial
MEDLINE INDUSTRIES, LP - Northfield recalls CURAD Alcohol Prep PadsSubpotent Drug- isopropyl alcohol levels fall below the labeled concentration.
-
Class IIofficial
MEDLINE INDUSTRIES, LP - Northfield recalls ReliOnSubpotent Drug- isopropyl alcohol levels fall below the labeled concentration.
-
Class IIofficial
MEDLINE INDUSTRIES, LP - Northfield recalls H-E-BSubpotent Drug- isopropyl alcohol levels fall below the labeled concentration.
-
Class IIofficial
MEDLINE INDUSTRIES, LP - Northfield recalls Good Neighbor PharmacySubpotent Drug- isopropyl alcohol levels fall below the labeled concentration.
-
Class IIofficial
MEDLINE INDUSTRIES, LP - Northfield recalls RITE AID PHARMACYSubpotent Drug- isopropyl alcohol levels fall below the labeled concentration.
-
Class IIofficial
FDC Limited recalls Timolol Maleate Ophthalmic Solution USPDefective Container: spike of the cap becomes lodged in the nozzle of the product bottle.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mgLabeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027
-
Class IIofficial
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalls PERIPHERAL PARENTERAL NUTRITIONLack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.
-
Class IIofficial
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Omeprazole Delayed-release CapsulesPresence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.
-
Class IIofficial
Cipla USA, Inc. recalls Budesonide Inhalation SuspensionLack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls clomiPRAMINE Hydrochloride Capsules USP 25 mgFailed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
-
Class Iofficial
Sandoz Inc recalls Cefazolin for InjectionLabeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit. The vials contained Cefozalin
-
Class Iofficial
Sandoz Inc recalls Buffered Penicillin G Potassium for InjectionLabeling: Label Mix-Up; Some vials of Cefazolin for Injection, USP 1 gram were incorrectly labeled as penicillin G potassium for Injection, USP, 20 million Unit
-
Class IIIofficial
AvKARE recalls Pitavastatin TabletsFailed Impurity/Degradation Specifications
-
Class IIIofficial
AvKARE recalls Pitavastatin TabletsFailed Impurity/Degradation Specifications
-
Class IIofficial
Granules Pharmaceuticals Inc. recalls Metoprolol Succinate Extended-Release TabletsFailed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.
-
Class IIofficial
Accord Healthcare, Inc. recalls Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specification
-
Class IIofficial
Accord Healthcare, Inc. recalls Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specification
-
Class IIofficial
Accord Healthcare, Inc. recalls Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specification
-
Class IIofficial
Accord Healthcare, Inc. recalls Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specification
-
Class IIofficial
Accord Healthcare, Inc. recalls Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specification
-
Class IIofficial
Accord Healthcare, Inc. recalls Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specification
-
Class IIofficial
Accord Healthcare, Inc. recalls Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specification
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mgProduct Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
-
Class IIofficial
The Harvard Drug Group LLC recalls Gabapentin CapsulesDefective container; blister packaging inadequately sealed.
-
Class IIofficial
The Harvard Drug Group LLC recalls Gabapentin CapsulesDefective container; blister packaging inadequately sealed.
-
Class IIofficial
B Braun Medical Inc recalls 0.9% Sodium Chloride Injection USPLack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).
-
Class IIIofficial
Qualgen, LLC recalls Testosterone 200 mg Pellet packaged in 1mL amber vialsLabeling: Incorrect or Missing Lot and/or Exp. Date: A printing issue resulted in incorrect lot numbers on the label.
-
Class IIIofficial
Macleods Pharmaceuticals Ltd recalls Famciclovir TabletsPresence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.
-
Class IIIofficial
Orient Pharma Co., Ltd. Yunlin Plant recalls Pitavastatin TabletsFailed Impurities/Degradation Specifications.
-
Class IIIofficial
Orient Pharma Co., Ltd. Yunlin Plant recalls Pitavastatin TabletsFailed Impurities/Degradation Specifications.
-
Class IIofficial
Immunocore, LLC recalls KIMMTRAK (tebentafusp-tebn) InjectionSubpotent Drug
-
Class Iofficial
Church & Dwight Inc recalls ZICAM COLD REMEDY MEDICATED NASAL SWABSMicrobial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.
-
Class Iofficial
Church & Dwight Inc recalls ZICAM NASAL ALLCLEARMicrobial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.
-
Class Iofficial
Church & Dwight Inc recalls Orajel BabyMicrobial Contamination of Non-Sterile Products: Fungal contamination of infant oral swabs.
-
Class Iofficial
Amneal Pharmaceuticals, LLC recalls Sulfamethoxazole and Trimethoprim TabletsMicrobial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.
-
Class IIofficial
Tailstorm Health INC recalls LIDOcaine HCl InjectionLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
-
Class IIofficial
Tailstorm Health INC recalls BUPIVAcaine HCL Sterile injectionLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
-
Class IIofficial
Tailstorm Health INC recalls KETAmine Hydrochloride InjectionLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
-
Class IIofficial
Tailstorm Health INC recalls KETAmine Hydrochloride InjectionLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
-
Class IIofficial
Tailstorm Health INC recalls LIDOcaine HCL Sterile InjectionLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.